Rapid Micro Biosystems, Inc.
RPID · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $39 | $32 | $48 | $441 |
| - Cash | $17 | $24 | $27 | $178 |
| + Debt | $6 | $7 | $8 | $0 |
| Enterprise Value | $28 | $15 | $29 | $263 |
| Revenue | $28 | $23 | $17 | $23 |
| % Growth | 24.6% | 31.4% | -26.3% | – |
| Gross Profit | -$0 | -$5 | -$9 | -$8 |
| % Margin | -0.4% | -24.4% | -49.8% | -33.3% |
| EBITDA | -$47 | -$53 | -$60 | -$46 |
| % Margin | -166% | -237.4% | -352.4% | -196.7% |
| Net Income | -$47 | -$52 | -$61 | -$74 |
| % Margin | -167.2% | -233% | -354.9% | -316.5% |
| EPS Diluted | -1.08 | -1.22 | -1.43 | -1.88 |
| % Growth | 11.5% | 14.7% | 23.9% | – |
| Operating Cash Flow | -$44 | -$45 | -$59 | -$55 |
| Capital Expenditures | -$1 | -$2 | -$7 | -$3 |
| Free Cash Flow | -$46 | -$47 | -$65 | -$58 |